ReviewPharmaceutics2023

Expanding the Availability of Onasemnogene Abeparvovec to Older Patients: The Evolving Treatment Landscape for Spinal Muscular Atrophy.

Charlotte A René et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.